Modulation of mast cell and basophil functions by benzene metabolites

Current Pharmaceutical Design

Volumn 17, Issue 34, 2011, Pages 3830-3835

  Triggiani, Massimo ^a   Loffredo, Stefania ^a   Granata, Francescopaolo ^a   Staiano, Rosaria I ^a   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Basophils; Benzene; Benzoquinone; Cytokines; Histamine; Hydroquinone; Mast cells

Indexed keywords

BENZENE; BENZENE DIHYDRODIOL; BENZENE EPOXIDE; BENZOQUINONE; CATECHOL; DRUG METABOLITE; HYDROQUINONE; PHENOL; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ARTICLE; BASOPHIL; CELL FUNCTION; DRUG EFFECT; DRUG EXPOSURE; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MAST CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 83455255103     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211798357863     Document Type: Article

References (86)

1. Atkinson TJ. A review of the role of benzene metabolites and mechanisms in malignant transformation: summative evidence for a lack of research in nonmyelogenous cancer types. Int J Hyg Environ Health 2009; 212: 1-10.
2. Snyder R, Witz G, Goldstein BD. The toxicology of benzene. Environ Health Perspect 1993; 100: 293-306.
3. Borrelli I, Loffredo S, Staiano RI, et al. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils. Int J Immunopathol Pharmacol 2010; 23: 737-744.
4. Snyder R. Xenobiotic metabolism and the mechanism(s) of benzene toxicity. Drug Metab Rev 2004; 36: 531-547.
5. Gillis B, Gavin IM, Arbieva Z, King ST, Jayaraman S, Prabhakar BS. Identification of human cell responses to benzene and benzene metabolites. Genomics 2007; 90: 324-333.
6. Sammett D, Lee EW, Kocsis JJ, Snyder R. Partial hepatectomy reduces both metabolism and toxicity of benzene. J Toxicol Environ Health 1979; 5: 785-792.
7. Giuliano M, Stellavato A, Cammarota M, et al. Effects of low concentrations of benzene on human lung cells in vitro. Toxicol Lett 2009; 188: 130-136.
8. Lo Pumo R, Bellia M, Nicosia A, Micale V, Drago F. Long-lasting neurotoxicity of prenatal benzene acute exposure in rats. Toxicology 2006; 223: 227-234.
9. EPA (United States Environmental Protection Agency) Integrated Risk Information System (IRIS) on benzene. National Center for Environmental Assessment, Office of Research and Development, Washington, DC. 2002.
10. Gut I, Nedelcheva V, Soucek P, Stopka P, Tichavska B. Cytochromes P450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environ Health Perspect 1996; 104 Suppl 6: 1211-1218.
11. Valentine JL, Lee SS, Seaton MJ, et al. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol Appl Pharmacol 1996; 141: 205-213.
12. Irons RD, Dent JG, Baker TS, Rickert DE. Benzene is metabolized and covalently bound in bone marrow in situ. Chem Biol Interact 1980; 30: 241-245.
13. Irons RD, Neptun DA. Effects of the principal hydroxy-metabolites of benzene on microtubule polymerization. Arch Toxicol 1980; 45: 297-305.
14. Monks TJ, Butterworth M, Lau SS. The fate of benzene-oxide. Chem Biol Interact 2010; 184: 201-206.
15. Ross D. The role of metabolism and specific metabolites in benzene- induced toxicity: evidence and issues. J Toxicol Environ Health A 2000; 61: 357-372.
16. Snyder R, Hedli CC. An overview of benzene metabolism. Environ Health Perspect 1996; 104 Suppl 6: 1165-1171.
17. Greenlee WF, Gross EA, Irons RD. Relationship between benzene toxicity and the disposition of 14C-labelled benzene metabolites in the rat. Chem Biol Interact 1981; 33: 285-299.
18. Smart RC, Zannoni VG. DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol Pharmacol 1984; 26: 105-111.
19. Golding BT, Watson WP. Possible mechanisms of carcinogenesis after exposure to benzene. IARC Sci Publ 1999: 75-88.
20. Kariya K, Lee E, Hirouchi M, Hosokawa M, Sayo H. Purification and some properties of peroxidases of rat bone marrow. Biochim Biophys Acta 1987; 911: 95-101.
21. Henderson RF. Species differences in the metabolism of benzene. Environ Health Perspect 1996; 104 Suppl 6: 1173-1175.
22. Kalf GF, Renz JF, Niculescu R. P-Benzoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins-1 α and -1 β to active cytokines by inhibition of the processing enzymes, calpain, and interleukin-1 b converting enzyme. Environ Health Perspect 1996; 104 Suppl 6: 1251-1256.
23. Irons RD, Stillman WS. Impact of benzene metabolites on differentiation of bone marrow progenitor cells. Environ Health Perspect 1996; 104 Suppl 6: 1247-1250.
24. Chanvaivit S, Navasumrit P, Hunsonti P, Autrup H, Ruchirawat M. Exposure assessment of benzene in Thai workers, DNA-repair capacity and influence of genetic polymorphisms. Mutat Res 2007; 626: 79-87.
25. Dougherty D, Garte S, Barchowsky A, Zmuda J, Taioli E. NQO1, MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of benzene exposure--a literature review. Toxicol Lett 2008; 182: 7-17.
26. Neafsey P, Ginsberg G, Hattis D, Johns DO, Guyton KZ, Sonawane B. Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity. J Toxicol Environ Health B Crit Rev 2009; 12: 362-388.
27. Brief RS, Lynch J, Bernath T, Scala RA. Benzene in the workplace. Am Ind Hyg Assoc J 1980; 41: 616-623.
28. Haley TJ. Evaluation of the health effects of benzene inhalation. Clin Toxicol 1977; 11: 531-548.
29. ATSDR (Agency for Toxic Substances and Disease Registry). Toxicological profile for Benzene. U.S. Department of Health and Human Services, Atlanta, GA. 1997.
30. Mehlman MA. Causal relationship between non-Hodgkin's lymphoma and exposure to benzene and benzene-containing solvents. Ann N Y Acad Sci 2006; 1076: 120-128.
31. Wong EY, Ray R, Gao DL, et al. Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. Int Arch Occup Environ Health 2006; 79: 251-258.
32. Yoon BI, Hirabayashi Y, Kawasaki Y et al. Exacerbation of benzene pneumotoxicity in connexin 32 knockout mice: enhanced proliferation of CYP2E1-immunoreactive alveolar epithelial cells. Toxicology 2004; 195: 19-29.
33. Veeramachaneni DN. Impact of environmental pollutants on the male: effects on germ cell differentiation. Anim Reprod Sci 2008; 105: 144-157.
34. Xiao G, Pan C, Cai Y, Lin H, Fu Z. Effect of benzene, toluene, xylene on the semen quality and the function of accessory gonad of exposed workers. Ind Health 2001; 39: 206-210.
35. Cakmak A, Ekici A, Ekici M, et al. Respiratory findings in gun factory workers exposed to solvents. Respir Med 2004; 98: 52-56.
36. Nicolai T, Carr D, Weiland SK, et al. Urban traffic and pollutant exposure related to respiratory outcomes and atopy in a large sample of children. Eur Respir J 2003; 21: 956-963.
37. Rumchev K, Spickett J, Bulsara M, Phillips M, Stick S. Association of domestic exposure to volatile organic compounds with asthma in young children. Thorax 2004; 59: 746-751.
38. Hirsch T, Weiland SK, von Mutius E, et al. Inner city air pollution and respiratory health and atopy in children. Eur Respir J 1999; 14: 669-677.
39. Zuskin E, Mustajbegovic J, Schachter EN, Doko-Jelinic J, Bradic V. Respiratory function in shoe manufacturing workers. Am J Ind Med 1997; 31: 50-55.
40. Albright JF, Goldstein RA. Airborne pollutants and the immune system. Otolaryngol Head Neck Surg 1996; 114: 232-238.
41. Goldstein BD. Benzene toxicity: a critical evaluation: hematotoxicity in humans. J Toxicol Environ Health Suppl 1977; 2: 69-105.
42. Thompson AJ, Shields MD, Patterson CC. Acute asthma exacerbations and air pollutants in children living in Belfast, Northern Ireland. Arch Environ Health 2001; 56: 234-241.
43. Ribeiro AL, Shimada AL, Hebeda CB, et al. In vivo hydroquinone exposure alters circulating neutrophil activities and impairs LPSinduced lung inflammation in mice. Toxicology 2011, on-line first; doi: 10.1016/j.tox.2011.05.009.
44. Cho JY. Suppressive effect of hydroquinone, a benzene metabolite, on in vitro inflammatory responses mediated by macrophages, monocytes, and lymphocytes. Mediators Inflamm 2008; 2008: 298010.
45. Choi JM, Cho YC, Cho WJ, Kim TS, Kang BY. Hydroquinone, a major component in cigarette smoke, reduces IFN-g production in antigen-primed lymphocytes. Arch Pharm Res 2008; 31: 337-341.
46. Kim E, Kang BY, Kim TS. Inhibition of interleukin-12 production in mouse macrophages by hydroquinone, a reactive metabolite of benzene, via suppression of nuclear factor-kB binding activity. Immunol Lett 2005; 99: 24-29.
47. Lee JY, Lee YG, Lee J, et al. Akt Cys-310-targeted inhibition by hydroxylated benzene derivatives is tightly linked to their immunosuppressive effects. J Biol Chem 2010; 285: 9932-9948.
48. Ma Q, Kinneer K, Ye J, Chen BJ. Inhibition of nuclear factor kB by phenolic antioxidants: interplay between antioxidant signaling and inflammatory cytokine expression. Mol Pharmacol 2003; 64: 211-219.
49. Marone G, Triggiani M, de Paulis A. Mast cells and basophils: friends as well as foes in bronchial asthma? Trends Immunol 2005; 26: 25-31.
50. de Paulis A, Montuori N, Prevete N, et al. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2. J Immunol 2004; 173: 5739-5748.
51. Marone G, Lichtenstein LM, Galli SJ. Mast Cells and Basophils. San Diego: Academic Press 2000.
52. Marshall JS, McCurdy JD, Olynych T. Toll-like receptor-mediated activation of mast cells: implications for allergic disease? Int Arch Allergy Immunol 2003; 132: 87-97.
53. Marone G, Triggiani M, Genovese A, De Paulis A. Role of human mast cells and basophils in bronchial asthma. Adv Immunol 2005; 88: 97-160.
54. Triggiani M, Giannattasio G, Balestrieri B, et al. Differential modulation of mediator release from human basophils and mast cells by mizolastine. Clin Exp Allergy 2004; 34: 241-249.
55. Aksoy M, Dincol K, Akgun T, Erdem S, Dincol G. Haematological effects of chronic benzene poisoning in 217 workers. Br J Ind Med 1971; 28: 296-302.
56. Pesatori AC, Garte S, Popov T, et al. Early effects of low benzene exposure on blood cell counts in Bulgarian petrochemical workers. Med Lav 2009; 100: 83-90.
57. Falcone FH, Haas H, Gibbs BF. The human basophil: a new appreciation of its role in immune responses. Blood 2000; 96: 4028-4038.
58. MacGlashan D Jr, Undem BJ. Inducing an anergic state in mast cells and basophils without secretion. J Allergy Clin Immunol 2008; 121: 1500-1506.
59. MacGlashan DW Jr. Self-termination/anergic mechanisms in human basophils and mast cells. Int Arch Allergy Immunol 2009; 150: 109-121.
60. Baolin L, Weiwei W, Ning T. Topical application of luteolin inhibits scratching behavior associated with allergic cutaneous reaction in mice. Planta Med 2005; 71: 424-428.
61. Theoharides TC, Kempuraj D, Iliopoulou BP. Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis. Adv Exp Med Biol 2007; 601: 423-430.
62. Qi X, Nishida J, Chaves L, Ohmori K, Huang H. CCAAT/Enhancer-binding Protein a (C/EBPa) Is Critical for Interleukin- 4 Expression in Response to FcεRI Receptor Cross-linking. J Biol Chem 2011; 286: 16063-16073.
63. 4+ T cells and increases immunoglobulin E levels in antigenprimed mice. Immunology 2002; 106: 496-502.
64. Lewis JG, Odom B, Adams DO. Toxic effects of benzene and benzene metabolites on mononuclear phagocytes. Toxicol Appl Pharmacol 1988; 92: 246-254.
65. Macedo SMD, Lourenco ELB, Borelli P, Fock RA, Ferreira JM, Jr., Farsky SHP. Effect of in vivo phenol or hydroquinone exposure on events related to neutrophil delivery during an inflammatory response. Toxicology 2006; 220: 126-135.
66. Macedo SMD, Vaz SC, Lourenco ELB, et al. In vivo hydroquinone exposure impairs allergic lung inflammation in rats. Toxicology 2007; 241: 47-57.
67. Matsui T, Ito C, Itoigawa M, Okada T, Furukawa H. Antiinflammatory activity of phenylpropanoids and phytoquinoids from Illicium species in RBL-2H3 cells. Planta Med 2007; 73: 662-665.
68. Goswami R, Kaplan MH. A brief history of IL-9. J Immunol; 186: 3283-3288.
69. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007; 7: 93-104.
70. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol; 10: 440-452.
71. Granata F, Nardicchi V, Loffredo S, et al. Secreted phospholipases A2: A proinflammatory connection between macrophages and mast cells in the human lung. Immunobiology 2009; 214: 811-821.
72. Aoyama K. Effects of benzene inhalation on lymphocyte subpopulations and immune response in mice. Toxicol Appl Pharmacol 1986; 85: 92-101.
73. Farris GM, Robinson SN, Wong BA, Wong VA, Hahn WP, Shah R. Effects of benzene on splenic, thymic, and femoral lymphocytes in mice. Toxicology 1997; 118: 137-148.
74. Rothman N, Li GL, Dosemeci M, et al. Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med 1996; 29: 236-246.
75. Rozen MG, Snyder CA. Protracted exposure of C57BL/6 mice to 300 ppm benzene depresses B- and T-lymphocyte numbers and mitogen responses. Evidence for thymic and bone marrow proliferation in response to the exposures. Toxicology 1985; 37: 13-26.
76. Pfeifer RW, Irons RD. Inhibition of lectin-stimulated lymphocyte agglutination and mitogenesis by hydroquinone: reactivity with intracellular sulfhydryl groups. Exp Mol Pathol 1981; 35: 189-198.
77. Pfeifer RW, Irons RD. Effect of benzene metabolites on phytohemagglutinin- stimulated lymphopoiesis in rat bone marrow. J Reticuloendothel Soc 1982; 31: 155-170.
78. Rozen MG, Snyder CA, Albert RE. Depressions in B- and Tlymphocyte mitogen-induced blastogenesis in mice exposed to low concentrations of benzene. Toxicol Lett 1984; 20: 343-349.
79. Li Q, Geiselhart L, Mittler JN, Mudzinski SP, Lawrence DA, Freed BM. Inhibition of human T lymphoblast proliferation by hydroquinone. Toxicol Appl Pharmacol 1996; 139: 317-323.
80. 4+ T lymphocytes. Toxicol Appl Pharmacol 1998; 149: 178-184.
81. Laskin DL, MacEachern L, Snyder R. Activation of bone marrow phagocytes following benzene treatment of mice. Environ Health Perspect 1989; 82: 75-79.
82. MacEachern L, Laskin DL. Increased production of tumor necrosis factor-a by bone marrow leukocytes following benzene treatment of mice. Toxicol Appl Pharmacol 1992; 113: 260-266.
83. MacEachern L, Snyder R, Laskin DL. Alterations in the morphology and functional activity of bone marrow phagocytes following benzene treatment of mice. Toxicol Appl Pharmacol 1992; 117: 147-154.
84. Manning BW, Adams DO, Lewis JG. Effects of benzene metabolites on receptor-mediated phagocytosis and cytoskeletal integrity in mouse peritoneal macrophages. Toxicol Appl Pharmacol 1994; 126: 214-223.
85. Klan MJ, Adams DO, Lewis JG. Effects of exposure to benzene in vivo on the murine mononuclear phagocyte system. Toxicol Appl Pharmacol 1990; 103: 198-205.
86. Ouyang Y, Virasch N, Hao P, et al. Suppression of human IL-1b, IL-2, IFN-g, and TNF-a production by cigarette smoke extracts. J Allergy Clin Immunol 2000; 106: 280-287.